Boehringer Ingelheim’s Mexico City expansion targets 5 billion tablets a year

Boehringer Ingelheim is investing 3.5 billion Mexican pesos (approximately US$187 million) to expand and modernize its pharmaceutical manufacturing site in Xochimilco, Mexico City. The…